Following successful small-animal trials that confirmed bioequivalence, BioNxt is now taking the final preclinical step to prepare its sublingual Cladribine formulation for human testing. The upcoming ...
Every year, millions of animals are used in laboratories, and for many people, the image is immediate and uncomfortable: ...